Skip to content
Search

Latest Stories

PSNC in talks with government on COVID-19 action plan for pharmacy

The Pharmaceutical Services Negotiating Committee (PSNC) said it has commenced discussions with the government regarding the recently published coronavirus action plan.

The organisation has discussed matters such as the provision of protective equipment for pharmacies, contingency funding for any pharmacies who need it, protection for pharmacies against sudden medicines price rises and ensuring the ongoing provision of pharmaceutical services in case of significant volumes of staff absences.


Much of these were build on previous discussions about the pandemic planning, PSNC stated in a statement.

Simon Dukes, PSNC Chief Executive, said: "The evolving COVID-19 situation is worrying for many people in the UK but particularly so for the health professionals on the front line. Community pharmacy teams are already putting themselves at risk dealing with this illness, and that will continue to be the case as this situation worsens. Pharmacies must be treated as a core part of the NHS in all epidemic planning, and PSNC will ensure that HM Government is aware of the critical part they have to play and the support – including financial – they will need through any epidemic."

Dukes said the government was in the “early stages of planning the response to COVID-19, building on the considerable pandemic planning work of the past.”

“There are many details still to be worked out and PSNC will be a part of those discussions, looking at how we can best protect the network of community pharmacies and allow them to continue their crucial work through this crisis. We will continue to update contractors as often as we can," he added.

NHS England and Improvement recently published an initial coronavirus guidance for community pharmacy. PSNC said the government’s latest action plan will be supported by further guidance to the NHS, including community pharmacies, in due course.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less